Health Care & Life Sciences » Pharmaceuticals | Medlab Clinical Ltd.

Medlab Clinical Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
3,908.20
3,721.00
3,838.20
4,758.20
Depreciation, Depletion & Amortization
-
133.20
125.90
110.40
112.40
Other Funds
-
14.40
14.10
16.80
28.40
Funds from Operations
-
3,760.60
3,580.90
3,744.60
4,674.20
Changes in Working Capital
-
205.00
315.90
505.50
101.20
Net Operating Cash Flow
-
3,965.60
3,896.80
4,250.10
4,775.40
Capital Expenditures
-
192.50
79.60
66.70
96.50
Net Investing Cash Flow
-
192.50
79.60
66.70
96.50
Issuance/Reduction of Debt, Net
-
948.50
755.00
-
-
Net Financing Cash Flow
-
3,948.50
4,680.90
4,987.00
23,678.00
Net Change in Cash
-
206.90
685.60
696.20
18,835.10
Free Cash Flow
-
4,158.10
3,976.50
4,316.90
4,871.80
Change in Capital Stock
-
3,000.00
5,435.90
4,987.00
23,475.00
Exchange Rate Effect
-
2.60
18.80
26.10
29.00

About Medlab Clinical

View Profile
Address
66 McCauley Street
Alexandria New South Wales (NSW) 2015
Australia
Employees -
Website http://www.medlab.co
Updated 07/08/2019
Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. It operates through the Nutraceutical Sales and Pharmaceutical Research segments. Its products include BifidoBiotic, BioClean, Biotic Jnr.